TR199901274T2 - Farnezil protein transferaz inhibitörleri olarak yararli yeni trisiklik piperidinil bilesikleri - Google Patents

Farnezil protein transferaz inhibitörleri olarak yararli yeni trisiklik piperidinil bilesikleri

Info

Publication number
TR199901274T2
TR199901274T2 TR1999/01274T TR9901274T TR199901274T2 TR 199901274 T2 TR199901274 T2 TR 199901274T2 TR 1999/01274 T TR1999/01274 T TR 1999/01274T TR 9901274 T TR9901274 T TR 9901274T TR 199901274 T2 TR199901274 T2 TR 199901274T2
Authority
TR
Turkey
Prior art keywords
protein transferase
transferase inhibitors
farnesyl protein
compounds useful
piperidinyl compounds
Prior art date
Application number
TR1999/01274T
Other languages
English (en)
Inventor
B. Cooler Alan
K. Mallams Alan
M. Girijavallabhan Viyyoor
J.Doll Ronald
G. Taveras Arthur
Njoroge F.George
J. Baldwin John
C. Reader John
Original Assignee
Schering Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corporation filed Critical Schering Corporation
Publication of TR199901274T2 publication Critical patent/TR199901274T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576—Six-membered rings
    • C07F9/59—Hydrogenated pyridine rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Yeni formül (1.0) trisiklik bilesikleri veya farmasötik olarak kabul edilebilir tuzlari veya solvatlari sunulmaktadir. Ayrica enzim, farnezil protein transferaz inhibitörleri olan farmasötik bilesimler açiklanmaktadir. Öte yandan Ras fonksiyonunu inhibe etmek ve dolayisiyla anomral hücre büyümesini inhibe etmek için bir yöntem sunulmaktadir. Yöntem yeni trisiklik bilesigin biyolojik bir sisteme uygulanmasina dayanmaktadir. Özellikle yöntem insan gibi bir memelide anormal hücre büyümesini inhibe eder.
TR1999/01274T 1996-09-13 1997-09-11 Farnezil protein transferaz inhibitörleri olarak yararli yeni trisiklik piperidinil bilesikleri TR199901274T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US71370396A 1996-09-13 1996-09-13

Publications (1)

Publication Number Publication Date
TR199901274T2 true TR199901274T2 (tr) 1999-10-21

Family

ID=24867181

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1999/01274T TR199901274T2 (tr) 1996-09-13 1997-09-11 Farnezil protein transferaz inhibitörleri olarak yararli yeni trisiklik piperidinil bilesikleri

Country Status (19)

Country Link
EP (1) EP0931078B1 (tr)
JP (1) JP2001500507A (tr)
KR (1) KR20000036104A (tr)
CN (1) CN1237170A (tr)
AT (1) ATE345338T1 (tr)
AU (1) AU4337697A (tr)
BR (1) BR9712826A (tr)
CA (1) CA2265763A1 (tr)
CZ (1) CZ84199A3 (tr)
DE (1) DE69736950T2 (tr)
ES (1) ES2276435T3 (tr)
HU (1) HUP0000191A2 (tr)
ID (1) ID21218A (tr)
NO (1) NO991233L (tr)
NZ (1) NZ334452A (tr)
PL (1) PL332241A1 (tr)
SK (1) SK33099A3 (tr)
TR (1) TR199901274T2 (tr)
WO (1) WO1998011098A1 (tr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6433165B1 (en) 1998-01-21 2002-08-13 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
CA2319077A1 (en) 1998-01-21 1999-07-29 Yoshisuke Nakasato Chemokine receptor antagonists and methods of use therefor
US6509346B2 (en) 1998-01-21 2003-01-21 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
US6613905B1 (en) 1998-01-21 2003-09-02 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
US6503926B2 (en) 1998-09-04 2003-01-07 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
US6288083B1 (en) 1998-09-04 2001-09-11 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
US7271176B2 (en) 1998-09-04 2007-09-18 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use thereof
US6645966B2 (en) 2001-01-22 2003-11-11 Schering Corporation Treatment of malaria with farnesyl protein transferase inhibitors
AU2002257114A1 (en) * 2001-04-06 2002-10-21 Schering Corporation Treatment of malaria with farsenyl protein transferase inhibitors
US7541365B2 (en) 2001-11-21 2009-06-02 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
TWI291467B (en) 2002-11-13 2007-12-21 Millennium Pharm Inc CCR1 antagonists and methods of use therefor
NZ551603A (en) * 2004-06-24 2010-11-26 Incyte Corp N-substituted piperidines and their use as pharmaceuticals
WO2008045673A2 (en) * 2006-10-06 2008-04-17 Bausch & Lomb Incorporated Quinolone carboxylic acids, derivatives thereof, processes for its preparation and its use as antibacterial agents
US7632944B2 (en) * 2007-01-24 2009-12-15 Bausch & Lomb Incorporated Quinolone carboxylic acids, derivatives thereof, and methods of making and using same
US20110136790A1 (en) * 2008-07-23 2011-06-09 De Lera Ruiz Manuel Tricyclic Heterocyclic Derivatives and Methods of Use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1593417A (en) * 1976-12-22 1981-07-15 Squibb & Sons Inc Carbocyclic-fused pyrazolopyridine derivatives
US5089496A (en) * 1986-10-31 1992-02-18 Schering Corporation Benzo[5,6]cycloheptapyridine compounds, compositions and method of treating allergies
IL98572A (en) * 1990-06-22 1995-07-31 Schering Corp Bite-benzo or benzopyrido compounds Cyclohepta piperidine, piperidylidene and piperazine, preparations and methods of use.
JP2875393B2 (ja) * 1993-10-15 1999-03-31 シェーリング コーポレイション Ｇ−タンパク質機能の阻害および増殖性疾患の治療に有用な三環式カルバメート化合物
IL111235A (en) * 1993-10-15 2001-03-19 Schering Plough Corp Medicinal preparations for inhibiting protein G activity and for the treatment of malignant diseases, containing tricyclic compounds, some such new compounds and a process for the preparation of some of them

Also Published As

Publication number Publication date
CN1237170A (zh) 1999-12-01
DE69736950T2 (de) 2007-09-20
BR9712826A (pt) 1999-11-16
ATE345338T1 (de) 2006-12-15
EP0931078B1 (en) 2006-11-15
PL332241A1 (en) 1999-08-30
CZ84199A3 (cs) 1999-11-17
EP0931078A1 (en) 1999-07-28
KR20000036104A (ko) 2000-06-26
SK33099A3 (en) 2000-05-16
HUP0000191A2 (hu) 2001-04-28
AU4337697A (en) 1998-04-02
CA2265763A1 (en) 1998-03-19
WO1998011098A1 (en) 1998-03-19
NZ334452A (en) 2000-09-29
ES2276435T3 (es) 2007-06-16
DE69736950D1 (de) 2006-12-28
JP2001500507A (ja) 2001-01-16
NO991233D0 (no) 1999-03-12
NO991233L (no) 1999-05-12
ID21218A (id) 1999-05-06

Similar Documents

Publication Publication Date Title
TR199901274T2 (tr) Farnezil protein transferaz inhibitörleri olarak yararli yeni trisiklik piperidinil bilesikleri
MX9707562A (es) Compuestos triciclicos utiles para inhibir la funcion de la proteina g y para el tratamiento de enfermedades proliferativas.
ES2194986T3 (es) Compuestos de carbonil-piperazinilo y piperidinilo que inhiben la farnesil-protein-transferasa.
TR199801168T2 (tr) Interleukin-1 beta dönüstürücü enzim inhibitörleri.
ES2175087T3 (es) Compuestos triciclicos utiles en el tratamiento de trastornos de proliferacion celular.
CA2293706A1 (en) N-substituted urea inhibitors of farnesyl-protein transferase
AU8163398A (en) Inhibitors of alpha4beta1mediated cell adhesion
TR200103428T2 (tr) IMPDH enzim inhibitörleri.
BR9814817A (pt) Inibidores de apoptose de dipeptìdio e o uso dos mesmos
NO991234L (no) Trisykliske inhibitorer av farnesylproteintransferase
DK0937074T3 (da) Benzonaphthyridiner som bronkiale terapeutiske midler
AU2209500A (en) Inhibitors of alpha4beta1 mediated cell adhesion
HUP9903166A2 (hu) Gyógyászati készítmények arterioszklerózis megelőzésére vagy kezelésére
MY143570A (en) Compounds useful for inhibition of farnesyl protein transferase
ES2169073T3 (es) Composiciones en forma de soluciones solidas.
HK1018783A1 (en) BENZO[C]QUINOLIZINE DERIVATIVES, THEIR PREPARATION AND USE AS 5 α-REDUCTASES INHIBITORS
TR199901275T2 (tr) Farnezil protein transferaz inhibisyonu için yararli bilesikler.
CA2293358A1 (en) Tricyclic sulfonamide inhibitors of farnesyl-protein transferase
DE69926078D1 (en) Farnesyl-protein transferase inhibitoren
ATE240313T1 (de) Tricyclische n-cyanoimine als inhibitoren der farnesyl-protein transferase
DK0925064T3 (da) 5-Androsten-3-beta,17-alpha-diol som inhibitor for tumorvækst
ATE236149T1 (de) Tricyclische aminooxyamide derivate als farnesyl protein transferase inhibitoren
CA2293549A1 (en) Phenyl-substituted tricyclic inhibitors of farnesyl-protein transferase
MX9701532A (es) Procedimiento para aumentar los niveles de testosterona.